title

Cytel Podcasts

Cytel

0
Followers
1
Plays
Cytel Podcasts
Cytel Podcasts

Cytel Podcasts

Cytel

0
Followers
1
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

The Cytel global team of professionals is here to help you address an array of challenges when conducting drug development. Whether you face a complex statistical issue or the need for knowledgeable collaborators to handle biometrics and trial implementation, Cytel has skilled professionals available when you need them.

Latest Episodes

Regulatory Perspective of Trial Design Innovations in Rare Disease Development

In a two-part interview, Cytel consulting statistician Ursula Garczarek reveals on how rare disease development is benefitting from adaptive trial approaches.

20 MINJAN 17
Comments
Regulatory Perspective of Trial Design Innovations in Rare Disease Development

East and the Independent Statistician: Answering the Toughest Development Questions

A new breed of independent statisticians like Lukas Makris are using East to harness the same predictive and assessment power enjoyed by bigger pharma. With East, innovative approaches are within the grasp of the smaller developers.

33 MIN2018 DEC 29
Comments
East and the Independent Statistician: Answering the Toughest Development Questions

EnForeSys Clinical Trial Enrollment Prediction Software

nForeSys puts you in control of the many factors affecting enrollment. EnForeSys incorporates realistic trial assumptions, based on historical data, into your predictions. You can make data-driven decisions about recruitment, quantifying your confidence in various enrollment strategies with high accuracy.

5 MIN2018 DEC 28
Comments
EnForeSys Clinical Trial Enrollment Prediction Software
the END

Latest Episodes

Regulatory Perspective of Trial Design Innovations in Rare Disease Development

In a two-part interview, Cytel consulting statistician Ursula Garczarek reveals on how rare disease development is benefitting from adaptive trial approaches.

20 MINJAN 17
Comments
Regulatory Perspective of Trial Design Innovations in Rare Disease Development

East and the Independent Statistician: Answering the Toughest Development Questions

A new breed of independent statisticians like Lukas Makris are using East to harness the same predictive and assessment power enjoyed by bigger pharma. With East, innovative approaches are within the grasp of the smaller developers.

33 MIN2018 DEC 29
Comments
East and the Independent Statistician: Answering the Toughest Development Questions

EnForeSys Clinical Trial Enrollment Prediction Software

nForeSys puts you in control of the many factors affecting enrollment. EnForeSys incorporates realistic trial assumptions, based on historical data, into your predictions. You can make data-driven decisions about recruitment, quantifying your confidence in various enrollment strategies with high accuracy.

5 MIN2018 DEC 28
Comments
EnForeSys Clinical Trial Enrollment Prediction Software
the END